Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer (Q33397708)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer |
scientific article |
Statements
1 reference
Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer (English)
1 reference
Jerzy Kozielski
1 reference
Zsuzsanna Márk
1 reference
Petr Zatloukal
1 reference
Barna Szima
1 reference
István Albert
1 reference
Erzsébet Juhász
1 reference
Jean-Louis Pujol
1 reference
Nigel Baker
1 reference
Dominic Smethurst
1 reference
Yong-jiang Hei
1 reference
Avi Ashkenazi
1 reference
Howard Stern
1 reference
Lukas Amler
1 reference
Yang Pan
1 reference
17 October 2011
1 reference
1 reference
Identifiers
1 reference